| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +277K | 96.2% | $13.06 | +$3.62M |
| Sells | 1 | -11K | 3.8% | $13.99 | -$154K |
| Net | 0 | +266K | 92.4% | +$3.46M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Alexander J. Denner | More than 10% owner | $117M | +$3.62M | +3.2% | Jun 15, 2023 |
| George Bickerstaff | Director | $2.2M | Apr 25, 2022 | ||
| Jules Haimovitz | Director | $1.88M | May 22, 2023 | ||
| Kostas D. Odysseas | Director | $1.74M | May 22, 2023 | ||
| Sarah J. Schlesinger | Director | $1.68M | May 22, 2023 | ||
| Mark DiPaolo | Director | $1.68M | May 22, 2023 | ||
| Deborah Birx | Director | $947K | May 22, 2023 | ||
| Marianne Zhen | Chief Accounting Officer | $708K | -$154K | -17.9% | Mar 5, 2024 |
| Matthew Ronsheim | Officer | $607K | Mar 5, 2024 | ||
| Sapna Srivastava | Director | $484K | May 22, 2023 | ||
| Pavel Raifeld | Chief Executive Officer | $184K | Mar 5, 2024 | ||
| Stephen Basso | Chief Financial Officer | $180K | Mar 5, 2024 | ||
| Larry Edwards | CEO of La Jolla Pharmaceutical | Aug 22, 2022 | |||
| GSK plc | More than 10% owner | May 20, 2021 | |||
| Margaret Koziel | Chief Medical Officer | Jul 31, 2023 | |||
| Derek Small | Director | Apr 29, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|